ERS Genomics appoints John E Milad as Chief Executive Officer

FHS
May 13, 2024
11:00 am

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

Cannabis Stocks Soar and how to make money in the stock market with MSOS stock

August 31, 2023

It’s Time to Study Earlier Use of Biologics in Children With Asthma, Says Expert

In this exclusive MedPage Today video, Leonard Bacharier, MD, of Vanderbilt University Medical Center in Nashville, Tennessee, explains how precision medicine and early intervention could

March 27, 2024

Year in Review: COVID-19

This year’s headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine safety, and potential therapeutics. COVID Deaths Are Down, but…

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.